Company Inspyr Therapeutics, Inc. Other OTC
Equities
NSPX
US45782A4031
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 10/10/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Ogilvie
BRD | Director/Board Member | 69 | 31/01/08 |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 11/10/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,000 | 0 | 0 | 100.00 % |
Stock B | 0 | 5,000 | 0 | 0 | |
Stock C | 0 | 290 | 0 | 0 | |
Stock D | 0 | 71 | 0 | 0 | |
Stock E | 0 | 134 | 0 | 0 | |
Stock F | 1 | 32,132,907 | 32,132,903 ( 100.00 %) | 0 | |
Stock G | 0 | 8,000 | 0 | 0 |
Company contact information
Rebus Holdings, Inc.
2629 Townsgate Road Suite 215
91361, Westlake Village
+818-661-6302
http://www.inspyrtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |